Castle Biosciences, Inc. (CSTL)

Last Closing Price: 33.41 (2026-11-19)

Debt to Equity Ratio (Quarterly)

Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity

Castle Biosciences, Inc. (CSTL) had Debt to Equity Ratio of 0.02 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$102.89M
$-4.10M
$23.92M
$78.97M
$105.62M
$-2.73M
$-1.07M
$-3.80M
$-3.80M
$-4.10M
$-4.10M
$-4.10M
$-4.10M
$-2.73M
$1.10M
30.63M
30.63M
$-0.13
$-0.13
Balance Sheet Financials
$356.86M
$111.46M
$222.55M
$579.41M
$67.61M
$6.15M
$33.35M
$100.96M
$478.44M
$386.95M
$478.44M
30.77M
Cash Flow Statement Financials
$12.81M
$-46.49M
$-5.05M
$116.73M
$77.99M
$-38.73M
$32.60M
--
--
Fundamental Metrics & Ratios
5.28
--
--
0.01
Debt to Equity Ratio
0.02
76.75%
-2.65%
-2.65%
--
-3.70%
-3.98%
$-15.76M
--
--
--
0.18
2.30
1.97
45.57
-0.86%
-1.06%
-0.71%
-0.85%
$15.55
$-0.51
$0.42